Related Experiment Videos
Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics
Journal of Pharmaceutical Sciences
|January 1, 1985
Summary
A new method simplifies bioavailability assessment for nonlinear drugs. This approach uses a disposition function derived from elimination data, offering a rational alternative to complex pharmacokinetic models for autonomic drug elimination.
Area of Science:
- Pharmacokinetics
- Drug Metabolism
- Quantitative Pharmacology
Background:
- Current bioavailability evaluation for nonlinear drugs relies on specific pharmacokinetic models.
- Linear pharmacokinetics typically uses model-independent methods like area under the curve (AUC).
- A gap exists for a universal, model-independent method for nonlinear drug bioavailability.
Purpose of the Study:
- To present a novel, model-independent method for evaluating drug bioavailability.
- To address drugs exhibiting nonlinear disposition kinetics and autonomic elimination.
- To provide a rational approach applicable to various nonlinear elimination functions.
Main Methods:
- The method applies to drugs with autonomic disposition (dC/dt = -q(C)).
- It is limited to drugs with a short distribution phase relative to elimination.
- The disposition function q(C) is empirically evaluated from elimination-phase data.
Main Results:
- The disposition function q(C) can be empirically determined.
- This function allows for the calculation of absolute bioavailability for autonomic, nonlinear drugs.
- Preliminary results demonstrate the practical application of the method.
Conclusions:
- A novel, rational method for assessing bioavailability in nonlinear drugs is established.
- The method is applicable to autonomic drug elimination, offering broader utility.
- This approach provides a structureless alternative to model-dependent evaluations for specific drug classes.